Cargando…
Clinical Aspects and Management of Levodopa-Induced Dyskinesia
In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa do...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372050/ https://www.ncbi.nlm.nih.gov/pubmed/22701811 http://dx.doi.org/10.1155/2012/745947 |
_version_ | 1782235315622117376 |
---|---|
author | Tambasco, Nicola Simoni, Simone Marsili, Erica Sacchini, Elisa Murasecco, Donatella Cardaioli, Gabriela Rossi, Aroldo Calabresi, Paolo |
author_facet | Tambasco, Nicola Simoni, Simone Marsili, Erica Sacchini, Elisa Murasecco, Donatella Cardaioli, Gabriela Rossi, Aroldo Calabresi, Paolo |
author_sort | Tambasco, Nicola |
collection | PubMed |
description | In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa dosing or the early use of dopamine agonists. Dopamine agonists with different pharmacological profile are available. Our paper was aimed to analyse the clinical impact and the management of dyskinesias with dopamine agonists. |
format | Online Article Text |
id | pubmed-3372050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33720502012-06-14 Clinical Aspects and Management of Levodopa-Induced Dyskinesia Tambasco, Nicola Simoni, Simone Marsili, Erica Sacchini, Elisa Murasecco, Donatella Cardaioli, Gabriela Rossi, Aroldo Calabresi, Paolo Parkinsons Dis Review Article In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa dosing or the early use of dopamine agonists. Dopamine agonists with different pharmacological profile are available. Our paper was aimed to analyse the clinical impact and the management of dyskinesias with dopamine agonists. Hindawi Publishing Corporation 2012 2012-06-03 /pmc/articles/PMC3372050/ /pubmed/22701811 http://dx.doi.org/10.1155/2012/745947 Text en Copyright © 2012 Nicola Tambasco et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Tambasco, Nicola Simoni, Simone Marsili, Erica Sacchini, Elisa Murasecco, Donatella Cardaioli, Gabriela Rossi, Aroldo Calabresi, Paolo Clinical Aspects and Management of Levodopa-Induced Dyskinesia |
title | Clinical Aspects and Management of Levodopa-Induced Dyskinesia |
title_full | Clinical Aspects and Management of Levodopa-Induced Dyskinesia |
title_fullStr | Clinical Aspects and Management of Levodopa-Induced Dyskinesia |
title_full_unstemmed | Clinical Aspects and Management of Levodopa-Induced Dyskinesia |
title_short | Clinical Aspects and Management of Levodopa-Induced Dyskinesia |
title_sort | clinical aspects and management of levodopa-induced dyskinesia |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372050/ https://www.ncbi.nlm.nih.gov/pubmed/22701811 http://dx.doi.org/10.1155/2012/745947 |
work_keys_str_mv | AT tambasconicola clinicalaspectsandmanagementoflevodopainduceddyskinesia AT simonisimone clinicalaspectsandmanagementoflevodopainduceddyskinesia AT marsilierica clinicalaspectsandmanagementoflevodopainduceddyskinesia AT sacchinielisa clinicalaspectsandmanagementoflevodopainduceddyskinesia AT muraseccodonatella clinicalaspectsandmanagementoflevodopainduceddyskinesia AT cardaioligabriela clinicalaspectsandmanagementoflevodopainduceddyskinesia AT rossiaroldo clinicalaspectsandmanagementoflevodopainduceddyskinesia AT calabresipaolo clinicalaspectsandmanagementoflevodopainduceddyskinesia |